Vancomycin for MRSA: Why Clinicians Are Reconsidering the Gold Standard in 2026

Vancomycin for MRSA: Why Clinicians Are Reconsidering the Gold Standard in 2026   Key Takeaways For decades, vancomycin has served as the cornerstone of treatment for infections caused by methicillin resistant Staphylococcus aureus (MRSA). Its widespread adoption established it as the default empiric therapy across a broad range of clinical

Vancomycin – Overview

Basic Review - Vancomycin GlobalRPh Student writer Vancomycin is a drug that is beneficial in the case of life-threatening bacterial infections and should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. Common administration routes: intravenously, orally or by inhalation. The

Vancomycin for MRSA: Why Clinicians Are Reconsidering the Gold Standard in 2026